Search Results
Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA
SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
Clinical Trial: Sparsentan for Treatment of IgA Nephropathy
IgA Nephropathy: Developing a Non-Immunosuppressive Therapy
Complement Conference Plenary: Emerging Injury Drivers-IgAN, MN, FSGS, Diabetic Nephropathy Defined
Studio PROTECT: Irbesartan VS Sparsentan nella IgA Nephropathy
Clinical Trials in Nephrology: IgA Nephropathy
Episode 2 - IgAN & FSGS Series: Management, Treatment & Recommendations for Future Research in IgAN
Episode 4 - IgAN & FSGS Series: Management, Treatment & Recommendations for Future Research in FSGS
Nephrology Update: Highlights from ASN Kidney Week 2023
Clinical Trial Conference Series: FSGS
Driving innovation for patients with FSGS and IgAN
